Montefarm, Montenegro’s state-owned pharmaceutical wholesaler and distributor, has showcased robust financial health and a reliable supply chain throughout 2025. This performance is particularly significant given the rising costs and ongoing global supply pressures impacting the public healthcare system. According to Aleksandar Bogavac, the company’s Director, effective financial management and strategic cash-flow planning have been crucial in maintaining liquidity and ensuring consistent access to medicines and medical supplies across the country.
Regular funding inflows from the Health Insurance Fund, coupled with stringent expenditure controls, have allowed Montefarm to fulfill its obligations to suppliers punctually. This has ensured uninterrupted deliveries to its network of 55 state pharmacies and all public healthcare institutions nationwide. Bogavac emphasized that Montefarm’s operational focus prioritizes system reliability over commercial profitability, underscoring its role as a vital component of Montenegro’s healthcare infrastructure.
Reflecting on the previous year, Bogavac characterized 2025 as a time of operational stability and gradual enhancement despite external challenges. Key achievements included targeted cost rationalization, improved internal procedures, and more efficient logistics. Throughout the year, pharmacies within Montefarm’s network consistently received supplies without any significant shortages. In addition to retail distribution, Montefarm plays a crucial role in supplying hospitals, emergency services, and national immunization programs.
Despite ongoing disruptions in global pharmaceutical supply chains due to production bottlenecks and raw material shortages, Montefarm has successfully maintained supply continuity. Bogavac noted that potential disruptions are addressed through proactive procurement planning and effective communication with suppliers. The company can source equivalent medicines approved under Montenegro’s official pharmaceutical list when necessary. In instances of delays, alternative procurement channels and internal stock redistribution are employed to minimize impacts on patients and healthcare providers.
Montefarm faces rising operational pressures from increasing prices of medicines, energy, and logistics services. In response, the company has optimized distribution routes, enhanced warehouse efficiency, and implemented stronger cost controls. Bogavac clarified that Montefarm does not set medicine prices; these are regulated through national procurement frameworks. The company’s primary mandate involves ensuring transparent procurement processes and stable supply rather than influencing market pricing.
The liquidity position of Montefarm remains stable, with supplier payments synchronized with funding transfers from the Health Insurance Fund. Bogavac highlighted that predictable funding flows are essential for securing continuous deliveries and maintaining trust with both international and domestic suppliers. Coordination with the Ministry of Health further enhances planning capabilities, reduces shortage risks, and aligns healthcare needs with available resources.
In addressing ongoing global challenges—especially shortages of older or less commercially viable medicines—Bogavac indicated that improved risk-management practices have lessened exposure. These practices include maintaining higher safety stocks for critical medications and diversifying supplier bases. When a contracted supplier fails to deliver, Montefarm can procure from alternative authorized distributors to stabilize the market and ensure patient access. However, sourcing specialized medicines for rare conditions remains challenging due to regulatory hurdles.
Montefarm is also pursuing modernization initiatives through investments in digital systems aimed at enhancing inventory management, demand forecasting, and distribution oversight. These advancements are already improving operational visibility and expediting decision-making processes. Looking forward, the company plans to expand its pharmacy network with new locations in Sutomore and central Podgorica to enhance accessibility.
Strategic infrastructure development is also on the horizon, including plans for a modern distribution center adhering to European standards. As Montefarm celebrates 35 years of operation, management regards these investments as vital for strengthening long-term resilience and ensuring that Montenegro’s public healthcare system remains well-supplied in an increasingly complex pharmaceutical landscape.
